SBIR/STTR Research Award

Austere environment, durable, safe, glass equivalent auto injector container technology

Award identifier e87eb3b71c21b1c92f749d2c4ccce4b8945a73c710d069251293860f3a2f05e8Awarding agency Department of Defense · Office for Chemical and Biological Defense

Award amount

$160,501

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Office for Chemical and Biological Defense
Recipient company
SIO2 MEDICAL PRODUCTS INC
Proposal award date
2021-05-03
Contract end date
2021-11-02
UEI
MCUKF6KCCN84
Solicitation number
20.2
Topic code
CBD202-003

Research abstract

SiO2 Materials Science (SiO2) is a U.S. advanced medical technology company that produces high-performance, durable, glass-equivalent primary containers that are uniquely designed to store, transport, and protect drugs, including those that require cold-chain storage. SiO2 is an SBA Defense SBIR/STTR Innovation Portal (DSIP) small business. SiO2’s primary containers are wholly manufactured in the United States and are the only available glass-equivalent alternative to traditional Type I borosilicate glass. SiO2 manufactures medical-grade polymer primary containers, including those for autoinjectors, that are coated using Plasma-Enhanced Chemical Vapor Deposition (PECVD) with a thin (20 nanometer), transparent, glass-like layer that provides a highly effective barrier to environmental gases and leachables. SiO2 also uses these manufacturing techniques to deliver glass-equivalent, ready-to-use vials, silicone oil free syringes and lubricated plungers, as well as blood collection tubes and other medical cartridges. SiO2 has developed and industrialized a novel technique for applying thin, transparent silica-based coatings on the inside surface of polymer containers, including vials, pre-filled syringes, and cartridges. This same technique is be applied to the inside surface of autoinjector containers. SiO2 applies the silica coating to the container in a unit operation where the container serves as the plasma reactor vessel. This approach ensures precise control of the coating process and simplifies the scale-up. Scale-up is achieved by replicating each unit operation. The material properties of SiO2’s pre-filled syringes for drug delivery provide unparalleled drug stability for a wide range of complex biopharmaceuticals. In addition, the containers are shatterproof and up to 15 times more dimensionally consistent than glass containers. When used in autoinjectors and drug delivery pumps, SiO2’s containers and pre-filled syringes increase the performance reliability of these drug delivery devices compared to glass containers. SiO2’s silicone oil free syringe provides the safest most robust platform for drug delivery. SiO2’s hybrid material has superior chemical, mechanical, and thermal durability and can withstand significantly more force without breakage compared to a traditional borosilicate glass syringe. The strength of the flange and hub regions of SiO2’s syringes well exceed normal use in an autoinjector device. The flange strength is 3-5 times stronger than glass syringes. Forces applied to SiO2’s container during flange failure testing are at or above 900 N, which far exceed normal use in an autoinjector.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2021–2022). Reported award amounts total $1,017,670. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Defense

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.